Contact
Sports injuries

Sports injuries

Arthroscopic procedures and the use of absorbable implants are common for treating sports injuries, as they provide a secure graft fixation while allowing biocompatible absorption and eventual replacement by bone.

In the EU, sports injuries accounts for around 6.2 million people annually needing hospital treatment; 7% (402,000 cases) having to be admitted for further treatment.1

  • Team ball sports account for 42% of all hospital-treated sports injuries, with 71% of these linked to football.1

In the USA, it is estimated that 30 million children and adolescents participate in youth sport. High school athletes account for an estimated 2 million injuries, 500,000 doctors’ visits and 30,000 hospitalisations each year.2,3

  • Children between the ages of 5-14 account for an estimated 40% of all sports-related injuries treated in hospitals.2,4
Percentage of people treated in EU hospitals for sports injuries each year1

Number of people treated in US hospitals for top 5 sports injuries5

Anterior Cruciate Ligament (ACL)

There are more than 200,000 ACL injuries each year in the USA, with approximately half of them requiring knee reconstruction. Around 70% occur while playing agility sports such as basketball, soccer, skiing and football. Within this number, 70% are sustained through non-contact mechanisms and 30% from direct contact.6,7,8

  • In the USA, the estimated cost of treatment for ACL injured patients is over $1.7 billion annually.9
  • In the USA, the estimated cost per patient for ACL surgery and rehabilitation is between $17,000 and $25,000.9
Estimated cause of ACL injuries7

For many years, absorbable implants have been used by surgeons in preference to metal devices as they offer a number of advantages:

  • No distortion of MRI imaging
  • No risk of metal contamination
  • No need for a second surgical procedure to remove the implant

There is now a wide range of absorbable devices. Some of these include absorbable polymer implants which are presenting problems associated with extended periods of absorption, migration, strength properties and foreign body reactions.
Biocomposites has pioneered the development of calcium polymer composite materials with improved mechanical properties, which give support during the healing period, offer improved biocompatibility during absorption and allow healing by bony growth.

Library

Listed below are 4 of the most relevant articles for this specialty but there is much more unrivalled evidence to explore on our Library page.

Explore Library

References and regulatory statements

1. Injuries in the European Union, 5th Edition – Summary of injury statistics for the years 2010-2012 2. Stop Sports Injuries: Youth Sports Injury Statistics. American Orthopaedic Society for Sports Medicine, 2016. 9400 W. Higgins Rd, Ste 300, Rosemont, Illinois 60018. 3. JS Powell, KD Barber Foss, 1999. Injury patterns in selected high school sports: a review of the 1995-1997 seasons. J Athl Train. 34: 277-84. 4. Preserving the Future of Sport: From Prevention to Treatment of Youth Overuse Sports Injuries. AOSSM 2009 Annual Meeting Pre-Conference Program. Keystone, Colorado. 5. Consumer Product Safety Commission, USA; National Electronic Injury Surveillance System (NEISS) – https://www.cpsc.gov/s3fs-public/2015%20Neiss%20data%20highlights.pdf 6. ACL Injury: Does It Require Surgery?; American Academy of Orthopaedic Surgeons, September 2009; http://orthoinfo.aaos.org/topic.cfm?topic=A00297#A00297_R4_anchor 7. Griffin LY. Noncontact Anterior Cruciate Ligament Injuries: Risk Factors and Prevention Strategies. Journal of the American Academy of Orthopaedic Surgeons. 2000;8:141-150. 8. Anterior Cruciate Ligament Injury (ACL). Sports medicine; University of California, San Francisco. Dept. of Orthopaedic Surgery. https://www.ucsf.edu/ 9. Basic science of anterior cruciate ligament injury and repair; A. M. Kiapour, M. M. Murray; DOI: 10.1302/2046-3758.32.2000241 Published 4 February 2014; Bone and Joint Research. https://online.boneandjoint.org.uk/doi/full/10.1302/2046-3758.32.2000241

Note: See Bilok and Biosteon pages for regulatory statements.